Skip to main content

Table 1 Univariate analysis of clinical and pathological characteristics of 99 PR + breast cancer patients in relation to p-c-Jun and PR colocalization positivity using Odds ratio model

From: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy

p-c-Jun and PR colocalization
Variable Characteristics (−) N = 128 (+) N = 81 OR (Odds ratio) 95% CI (Confidence interval) P-value
Clinicopathological data
Age (Y) <50 6 33 0.73 0.2 to 2.3 0.56a
>50 12 48
Tumor size <20 mm 1 15 0.25 0.005 to 1.94 0.29b
>20 mm 17 66
Lymph node metastasis Negative 3 38 0.22 0.04 to 0.9 0.019b
Positive 15 43
Distant metastasis M0 17 76 1.1 0.1 to 56 1b
M1 1 5
Clinical stage I + II 11 50 0.97 0.3 to 3.3 0.96a
III + IV 7 31
Tumor grade Well to moderately differentiatedc 13 68 0.49 0.13 to 2.1 0.3b
Poorly differentiatedc 5 13
Estrogen receptor (ER) Negative 1 6 0.74 0.01 to 6.7 1b
Positive 17 75
  1. aχ2 Test.
  2. bFisher’s exact test.
  3. cWell to moderately differentiated: tumor grade 1 + 2; poorly differentiated: tumor grade 3.